Form 4: AMEDISYS Chief Accounting Officer Discloses Routine Stock Disposition for Tax Purposes
Insider Transaction Report
Allyson Guidroz, Chief Accounting Officer of Amedisys Inc., reported a disposition of 171 shares of common stock at $94.07 per share, primarily for tax withholding purposes, as detailed in a recent SEC Form 4 filing.
Summary
- Allyson Guidroz, the Chief Accounting Officer of Amedisys Inc. (AMED), filed a Form 4 with the SEC.
- The filing reports a transaction on June 1, 2025, involving the disposition of 171 shares of Amedisys Common Stock.
- The transaction code 'F' indicates that the shares were disposed of to satisfy tax withholding obligations related to the vesting of equity awards.
- The shares were disposed of at a price of $94.07 per share.
- Following this transaction, Ms. Guidroz directly beneficially owns 7,943 shares of Common Stock.
- Additionally, Ms. Guidroz indirectly owns 1.5 shares of Common Stock through a 401(k) Plan, based on a statement dated March 31, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction for tax withholding purposes, common for executives receiving equity compensation.
Industry Context
This filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends. It reflects an individual's compensation-related activity within the healthcare services sector.
Related Party Transactions
- The filing details a transaction by Allyson Guidroz, the Chief Accounting Officer of Amedisys Inc., which is considered an insider or related party transaction.
Stakeholder Impact
- The impact on shareholders is minimal as this is a small, routine disposition of shares by an executive for tax purposes and does not reflect a discretionary sale or change in company strategy.
- There is no direct impact on employees, customers, suppliers, or creditors from this specific transaction.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of the 401(k) Plan statement on which indirect beneficial ownership is based. |
| 06/01/2025 | Date of the reported transaction (disposition of common stock). |
| 06/03/2025 | Date the Form 4 was signed. |
Keywords
Amedisys Inc., AMED, Form 4, SEC filing, insider transaction, stock disposition, tax withholding, Chief Accounting Officer, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.